Skip to main content
Symbios logo

Symbios

Vitória, Espírito Santo, BrazilSee on the map

  • Neurorehabilitation and assistive tech

Symbios develops m-FLEX, a portable robotic platform for upper-limb neuromotor rehabilitation. Designed for use across clinics, hospital wards, and homes, it combines assisted movement, interactive therapeutic activities, and session-level progress tracking.

Raised
$25.2M
Investors
5

reccy insights

Recent highlights

Symbios has advanced its footprint in the digital health and medical device sector through the continuous development and deployment of its flagship m-FLEX platform. Designed to facilitate portable upper-limb neuromotor rehabilitation, the technology bridges clinical and home care environments. In October 2025, the company secured a Venture Capital financing round backed by Hopewell Ventures, pointing to continued interest in scalable, software-integrated robotic hardware for rehabilitation. Over the years, the company has bolstered its financial backing through multiple funding milestones, including grants and debt financing from institutional entities such as the National Science Foundation, National Cancer Institute, and the Department of Energy.

Written by reccy's AI from company sites, press and funding records · updated Nov 2026

What makes Symbios distinct

  1. 01Portable design lets therapists bring robotic rehabilitation beyond specialized clinical centers, without installation or a dedicated room.
  2. 02Supports elbow flexion and extension, forearm pronation and supination, and hand opening and closing in one system.
  3. 03Records repetitions, movement speed, robotic assistance, and patient progression to support objective monitoring across sessions.
  4. 04Integrates therapeutic activities and games to make rehabilitation sessions interactive.
  5. 05Designed to expand access to advanced rehabilitation across clinical, educational, research, and home settings.

Technology & products

  • m-FLEX

    A portable robotic platform for upper-limb neuromotor rehabilitation designed for clinics, hospital wards, and home use.

  • m-FLEX portable robotic rehabilitation platform
  • Robotic assistance for upper-limb movement across the elbow, forearm, and hand
  • Session tracking for repetitions, movement speed, assistance level, and patient progression
  • Therapeutic activities and games integrated into rehabilitation sessions

Research roots1

Labs and research groups this company came from or works with.

Academic data: Carter Sciences

Funding

$25.2M disclosed
  • Venture CapitalOct 2025
    Hopewell Ventures
  • DebtJan 2021
    $44KLed by PPP
  • GrantJan 2017
    $8.4MLed by DOE
5 investors

Investors7

Also backed by
  • National Cancer Institute
  • DOE
  • Hopewell Ventures
  • U.S. Small Business Administration
  • local investors

Similar companies

About Symbios

Products
m-FLEX
Focus areas
Healthcare, medical devices, digital health, rehabilitation, robotics, neuromotor rehabilitation, assistive technology, remote care
Headquarters
Vitória, Espírito Santo, Brazil